• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病和高血压。

Diabetes and hypertension.

作者信息

Mahler R J

机构信息

Department of Medicine, Cornell University Medical Center, New York.

出版信息

Horm Metab Res. 1990 Dec;22(12):599-607. doi: 10.1055/s-2007-1004983.

DOI:10.1055/s-2007-1004983
PMID:2076856
Abstract

Diabetes mellitus and hypertension constitute two powerful independent risk factors for cardiovascular, renal and atherosclerotic disease. The frequent occurrence of the two diseases in the same individual doubles the risk of cardiovascular death, as well as substantially increasing the frequency of transient ischemic attacks, strokes, peripheral vascular disease with lower extremity amputations, as well as end-stage renal disease and blindness. Although hypertension usually occurs in IDDM in association with renal disease, in NIDDM the evolution of hypertension appears to be multifactorial and independent of renal disease. Obesity appears to be dissociable from hypertension and NIDDM with a common link between obesity, hypertension and NIDDM appearing to be hyperinsulinism and insulin resistance. It has been suggested that hyperinsulinism and insulin resistance may lead to hypertension through altered intracellular calcium metabolism, enhanced renal sodium reabsorption, or through an effect of insulin upon lipid and/or catecholamine metabolism. Further, insulin itself may have a direct effect upon the atherosclerotic process in the hypertensive diabetic patient. These considerations have been taken into account in the structuring of antihypertensive therapy in Type I and Type II Diabetes Mellitus.

摘要

糖尿病和高血压是心血管、肾脏及动脉粥样硬化疾病的两大独立高危因素。这两种疾病在同一个体中频繁并发,会使心血管疾病死亡风险加倍,同时也会显著增加短暂性脑缺血发作、中风、伴有下肢截肢的外周血管疾病、终末期肾病及失明的发生频率。虽然高血压通常在胰岛素依赖型糖尿病(IDDM)中与肾病并发,但在非胰岛素依赖型糖尿病(NIDDM)中,高血压的发展似乎是多因素的,且与肾病无关。肥胖似乎与高血压和NIDDM没有关联,肥胖、高血压和NIDDM之间的共同联系似乎是高胰岛素血症和胰岛素抵抗。有人提出,高胰岛素血症和胰岛素抵抗可能通过改变细胞内钙代谢、增强肾脏对钠的重吸收,或通过胰岛素对脂质和/或儿茶酚胺代谢的影响而导致高血压。此外,胰岛素本身可能对高血压糖尿病患者的动脉粥样硬化进程有直接影响。在制定I型和II型糖尿病的抗高血压治疗方案时,已考虑到这些因素。

相似文献

1
Diabetes and hypertension.糖尿病和高血压。
Horm Metab Res. 1990 Dec;22(12):599-607. doi: 10.1055/s-2007-1004983.
2
Diabetes and hypertension: a review.糖尿病与高血压:综述
Prim Care. 1991 Sep;18(3):509-24.
3
[Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].[糖尿病患者的高血压——特定发病机制及治疗方面]
Przegl Lek. 2001;58(3):124-6.
4
[Insulin resistance and arterial hypertension].[胰岛素抵抗与动脉高血压]
Herz. 1995 Feb;20(1):16-32.
5
Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.高血压与碳水化合物代谢的细微及明显异常之间的关系。
J Am Soc Nephrol. 1990 Sep;1(3 Suppl 1):S39-47.
6
New drugs and clinical trials in diabetes and hypertension.糖尿病和高血压的新药与临床试验。
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:64-9. doi: 10.1055/s-0029-1211801.
7
[Insulin resistance and cardiovascular complications].[胰岛素抵抗与心血管并发症]
Wien Klin Wochenschr. 1994;106(24):758-62.
8
Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.胰岛素依赖型和非胰岛素依赖型糖尿病中微量白蛋白尿、胰岛素抵抗与肾心并发症之间的关系。
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:1-7. doi: 10.1055/s-0029-1211783.
9
Metabolic considerations in hypertension.高血压中的代谢因素
Am J Hypertens. 1990 Dec;3(12 Pt 2):355S-365S.
10
[Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].[糖尿病中的高血压、微量白蛋白尿与胰岛素抵抗]
Wien Klin Wochenschr. 1994;106(24):774-92.

引用本文的文献

1
Investigation of multimorbidity patterns and association rules in patients with type 2 diabetes mellitus using association rules mining algorithm.使用关联规则挖掘算法对2型糖尿病患者的共病模式和关联规则进行研究。
Sci Rep. 2025 Jul 16;15(1):25741. doi: 10.1038/s41598-025-09926-8.
2
Blood Pressure and Late Pregnancy Circulating miRNAs in the MADRES Study.MADRES研究中的血压与妊娠晚期循环微RNA
J Am Heart Assoc. 2025 Jun 17;14(12):e040416. doi: 10.1161/JAHA.124.040416. Epub 2025 Jun 11.
3
Consideration of inequalities in effectiveness trials of mHealth applications - a systematic assessment of studies from an umbrella review.
考虑移动健康应用有效性试验中的不平等现象 - 系统评估伞式综述中的研究。
Int J Equity Health. 2024 Sep 11;23(1):181. doi: 10.1186/s12939-024-02267-4.
4
Predictive model for persistent hypertension after surgical intervention of primary aldosteronism.原发性醛固酮增多症手术干预后持续性高血压的预测模型。
Sci Rep. 2023 Jul 22;13(1):11868. doi: 10.1038/s41598-023-39028-2.
5
Mechanisms mediating insulin-induced hypotension in rats. A role for nitric oxide and autonomic mediators.介导大鼠胰岛素诱导性低血压的机制。一氧化氮和自主神经介质的作用。
Acta Diabetol. 1996 Dec;33(4):263-8. doi: 10.1007/BF00571561.